GANGAPHARM.BO
Price:
$11.68
Market Cap:
$69.05M
Ganga Pharmaceuticals Ltd. engages in the manufacturing and trading of pharmaceuticals and allied products. It focuses on manufacturing, marketing, and distribution of Bulk Ayurvedic medicines. Its products include Ampachan Vati, Khadira Vati, and Nirmalaya churna. The firm offers acidity, antidandruff, antioxidants, constipation, dental care, diarrhea, ear care, female tonic, and joint pains ayurvedic medicines. The company was founded by Brijmohan C. Sharma in 1974 and is headquartered in Mumbai, India.
Industry
Medical - Pharmaceuticals
IPO Date
Stock Exchange
BSE
Ticker
GANGAPHARM.BO
According to Ganga Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current ROE is 1.11%. This represents a change of 142.01% compared to the average of 0.46% of the last 4 quarters.
The mean historical ROE of Ganga Pharmaceuticals Limited over the last ten years is 1.52%. The current 1.11% ROE has changed -26.61% with respect to the historical average. Over the past ten years (40 quarters), GANGAPHARM.BO's ROE was at its highest in in the September 2018 quarter at 2.91%. The ROE was at its lowest in in the March 2016 quarter at 0.05%.
Average
1.52%
Median
1.06%
Minimum
0.38%
Maximum
3.63%
Discovering the peaks and valleys of Ganga Pharmaceuticals Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 91.96%
Maximum Annual ROE = 3.63%
Minimum Annual Increase = -89.26%
Minimum Annual ROE = 0.38%
| Year | ROE | Change |
|---|---|---|
| 2025 | 1.11% | 67.65% |
| 2024 | 0.66% | -8.37% |
| 2023 | 0.72% | 2.97% |
| 2022 | 0.70% | 84.85% |
| 2021 | 0.38% | -89.26% |
| 2020 | 3.53% | -2.88% |
| 2019 | 3.63% | 91.96% |
| 2018 | 1.89% | 24.36% |
| 2017 | 1.52% | 50.06% |
| 2016 | 1.01% | -20.23% |
The current ROE of Ganga Pharmaceuticals Limited (GANGAPHARM.BO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0.83%
5-year avg
0.71%
10-year avg
1.52%
Ganga Pharmaceuticals Limited’s ROE is
| Company | ROE | Market cap |
|---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ganga Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ganga Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Ganga Pharmaceuticals Limited's ROE?
How is the ROE calculated for Ganga Pharmaceuticals Limited (GANGAPHARM.BO)?
What is the highest ROE for Ganga Pharmaceuticals Limited (GANGAPHARM.BO)?
What is the 3-year average ROE for Ganga Pharmaceuticals Limited (GANGAPHARM.BO)?
What is the 5-year average ROE for Ganga Pharmaceuticals Limited (GANGAPHARM.BO)?
How does the current ROE for Ganga Pharmaceuticals Limited (GANGAPHARM.BO) compare to its historical average?